Search research articles
Contact Us
Filters
Showing results (41-50 of 82) with videos related to
Page
of 9
Sort By:
Cancers
|
April 23, 2022
Combination of LIGHT (TNFSF14)-Armed Myxoma Virus Pre-Loaded into ADSCs and Gemcitabine in the Treatment of Experimental Orthotopic Murine Pancreatic Adenocarcinoma
Joanna Jazowiecka-Rakus, Aleksander Sochanik, Agata Hadryś, et al.
Virology
|
March 26, 2010
Myxoma and vaccinia viruses exploit different mechanisms to enter and infect human cancer cells
Nancy Y Villa, Eric Bartee, Mohamed R Mohamed, et al.
American Journal of Veterinary Research
|
August 2, 2012
Oncolysis of canine tumor cells by myxoma virus lacking the serp2 gene
Ashlee S Urbasic, Stacy Hynes, Amy Somrak, et al.
The Journal of Biological Chemistry
|
April 4, 2019
Myxoma virus M013 protein antagonizes NF-κB and inflammasome pathways via distinct structural motifs
Rekha R Garg, Cody B Jackson, Masmudur M Rahman, et al.
Immunity
|
January 14, 2021
A class of viral inducer of degradation of the necroptosis adaptor RIPK3 regulates virus-induced inflammation
Zhijun Liu, Himani Nailwal, Jonah Rector, et al.
Experimental Parasitology
|
May 22, 2022
Oncolytic Myxoma virus infects and damages the tegument of the human parasitic flatworm Schistosoma mansoni
Masmudur M Rahman, Grant McFadden, Gordon Ruthel, et al.
Oncotarget
|
January 21, 2021
NSCs are permissive to oncolytic <i>Myxoma virus</i> and provide a delivery method for targeted ovarian cancer therapy
Yvonne Cornejo, Min Li, Thanh H Dellinger, et al.
Leukemia Research
|
February 21, 2012
Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitro
Gerard J Madlambayan, Eric Bartee, Manbok Kim, et al.
Cancer Cell
|
August 26, 2022
Induction of tumor cell autosis by myxoma virus-infected CAR-T and TCR-T cells to overcome primary and acquired resistance
Ningbo Zheng, Jing Fang, Gang Xue, et al.
Clinical Medicine Insights. Oncology
|
February 26, 2021
The Oncolytic Activity of Myxoma Virus against Soft Tissue Sarcoma Is Mediated by the Overexpression of Ribonucleotide Reductase
Yanghee Woo, Susanne G Warner, Rula Geha, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 82) with videos related to
Sort By:
Page
of 9
Cancers
|
April 23, 2022
Combination of LIGHT (TNFSF14)-Armed Myxoma Virus Pre-Loaded into ADSCs and Gemcitabine in the Treatment of Experimental Orthotopic Murine Pancreatic Adenocarcinoma
Joanna Jazowiecka-Rakus, Aleksander Sochanik, Agata Hadryś, et al.
Virology
|
March 26, 2010
Myxoma and vaccinia viruses exploit different mechanisms to enter and infect human cancer cells
Nancy Y Villa, Eric Bartee, Mohamed R Mohamed, et al.
American Journal of Veterinary Research
|
August 2, 2012
Oncolysis of canine tumor cells by myxoma virus lacking the serp2 gene
Ashlee S Urbasic, Stacy Hynes, Amy Somrak, et al.
The Journal of Biological Chemistry
|
April 4, 2019
Myxoma virus M013 protein antagonizes NF-κB and inflammasome pathways via distinct structural motifs
Rekha R Garg, Cody B Jackson, Masmudur M Rahman, et al.
Immunity
|
January 14, 2021
A class of viral inducer of degradation of the necroptosis adaptor RIPK3 regulates virus-induced inflammation
Zhijun Liu, Himani Nailwal, Jonah Rector, et al.
Experimental Parasitology
|
May 22, 2022
Oncolytic Myxoma virus infects and damages the tegument of the human parasitic flatworm Schistosoma mansoni
Masmudur M Rahman, Grant McFadden, Gordon Ruthel, et al.
Oncotarget
|
January 21, 2021
NSCs are permissive to oncolytic <i>Myxoma virus</i> and provide a delivery method for targeted ovarian cancer therapy
Yvonne Cornejo, Min Li, Thanh H Dellinger, et al.
Leukemia Research
|
February 21, 2012
Acute myeloid leukemia targeting by myxoma virus in vivo depends on cell binding but not permissiveness to infection in vitro
Gerard J Madlambayan, Eric Bartee, Manbok Kim, et al.
Cancer Cell
|
August 26, 2022
Induction of tumor cell autosis by myxoma virus-infected CAR-T and TCR-T cells to overcome primary and acquired resistance
Ningbo Zheng, Jing Fang, Gang Xue, et al.
Clinical Medicine Insights. Oncology
|
February 26, 2021
The Oncolytic Activity of Myxoma Virus against Soft Tissue Sarcoma Is Mediated by the Overexpression of Ribonucleotide Reductase
Yanghee Woo, Susanne G Warner, Rula Geha, et al.
Page
of 9